Amanda Lemos Accepts 2-Year USADA Suspension for Positive Steroid Test

UFC bantamweight Amanda Lemos has accepted a two-year suspension from USADA for a positive steroid test.

The organization announced the sanction in a statement on Wednesday, revealing that Lemos tested positive for stanozolol and its metabolite in an out-of-competition drug screening conducted on Nov. 8. USADA’s statement is as follows:

USADA announced today that UFC athlete Amanda Lemos, of Belém, Brazil, has tested positive for a prohibited substance and accepted a two-year sanction for her anti-doping policy violation.

Lemos, 30, tested positive for stanozolol and its metabolite 16β-hydroxystanozolol following an out-of-competition urine test conducted on November 8, 2017. Stanozolol is a non-Specified Substance in the class of Anabolic Agents and prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List.

Lemos’ two-year period of ineligibility, the standard sanction for a first offense involving a non-Specified Substance, began on November 8, 2017, the date her positive sample was collected.

Pursuant to the UFC Anti-Doping Policy, all UFC athletes serving a period of ineligibility for an anti-doping policy violation are required to continue to make themselves available for testing in order to receive credit for time completed under their sanction.

Lemos made her Octagon debut at UFC Fight Night 113, losing to Leslie Smith via second-round TKO on July 16. The 30-year-old Brazilian posted a 6-0-1 mark on the regional circuit prior to falling to Smith.